| Jul 12 |
Lantheus' Strategic Advantage Amplified By New CMS Payment Refinements (Rating Upgrade)
|
| Jul 10 |
Lantheus Stock Gets A Radioactive Surge On Medicare Proposal
|
| Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
| Jul 10 |
Lantheus hits 52-week high on Medicare proposal (update)
|
| Jul 10 |
Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
|
| Jul 10 |
Why Lantheus Holdings Stock Is Skyrocketing Today
|
| Jul 8 |
Lantheus Appoints Jamie Spaeth as Chief People Officer
|
| Jul 5 |
Is Lantheus Holdings Inc (NASDAQ:LNTH) the Best Jim Cramer Stock in 2024?
|
| Jun 27 |
Lantheus acquires global rights to Life Molecular's drug for prostate and breast cancers
|
| Jun 27 |
Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
|
